IN SEVERE PULMONARY EDEMA, fluid may flood the alveolar spaces and impair the ability of the lungs to oxygenate the blood. Removal of this excess alveolar fluid is critical for the reestablishment of normal oxygen delivery but presents a formidable challenge because of the relatively low permeability of the alveolar epithelium. Recent studies have provided insight into how this problem is solved by showing that excess water is osmotically cleared from the alveolar spaces by a mechanism involving sodium transport across the alveolar epithelium (20, 24) . After removal from the air spaces, most of the reabsorbed fluid appears to rapidly enter the pulmonary vasculature and not be stored in the interstitium (10, 23) . The rate of transepithelial fluid and/or sodium movement has been shown to be accelerated in many species (including humans) by the administration of b-adrenergic agonists, such as terbutaline and epinephrine (3-8, 11, 13, 14, 16, 19, 22, 25) , and recent studies have indicated that endogenous catecholamines may be responsible for increasing alveolar liquid clearance (ALC) after the development of some forms of pulmonary edema (17, 21) .
Effros et al. (11) and Sakuma et al. (23) have shown that nonperfused lungs can retain the ability to absorb fluid from their air spaces for extended periods at rates comparable to those observed when the lungs were perfused, and Sakuma et al. (22) have recently capitalized on these observations by using nonperfused resected human lung lobes to examine the mechanisms of sodium and water transport in the human lung. Although isolated perfused lungs have been used by many investigators to study the process of liquid and solute transport across the alveolar epithelium, the above observations suggest that the isolated nonperfused lung might be a useful preparation as well and one in which the elimination of the need for perfusion might be advantageous. For example, in some studies, it may be desirable to study several lung lobes from the same animal simultaneously. This design would allow each animal to serve as its own control and allow for the evaluation of multiple experimental interventions in a single experiment, thus potentially minimizing the number of individual experiments and animals to be used. The ability to simultaneously study several lung lobes, however, may be limited by the technical requirements for perfusion. The elimination of the need for perfusion would thus increase the practicality of such experimental designs. Accordingly, to determine the feasibility of using this approach, we set up a system that allowed us to simultaneously measure ALC in three canine autologous nonperfused lung lobes. We used this preparation to conduct the following four groups of experiments. The first two groups were designed to determine whether the alveolar epithelium of this preparation retains its ability to remove fluid from the air spaces, the extent to which the epithelium remains responsive to b-adrenoceptor stimulation, and the variation in ALC among the three lobes under both of these conditions. The final two groups of experiments were designed to test the feasibility of using this approach to study the effects of multiple experimental interventions by evaluating the ability of a b-adrenoceptor antagonist and a Na 1 -K 1 -adenosinetriphosphatase (Na 1 -K 1 -ATPase) inhibitor to prevent the increase in ALC produced by b-adrenergic stimulation.
METHODS
Isolated nonperfused lung lobe preparation. Twenty-four dogs [21.2 6 4.1 (SD) kg] of mixed breed and sex were anesthetized with pentobarbital sodium (30 mg/kg iv), and polyethylene catheters were inserted into a femoral artery and vein. The dog's blood was heparinized (1,000 U/kg), and 13 ml/kg arterial blood were removed and replaced with an equal volume of dextran. The first 6 ml of blood were used for plasma catecholamine analysis by high-performance liquid chromatography as previously described (18) . The remaining blood was centrifuged, and the plasma was removed and saved for later instillation into the lungs. The animal was then killed with an overdose of pentobarbital sodium, the chest was opened, and the lungs were removed. At this time, an additional blood sample for catecholamine analysis was taken from the left ventricle. The left lower (LLL), right lower (RLL), and right middle lung lobes (RML) were separated and weighed, and a plastic cannula was tied into each airway. The lung lobes were placed in plastic bags and connected by their cannulas to a manifold system that consisted of a central airway with three ports that allowed the lobes to be attached. The lobes were reinflated with a heated (37°C) humidified gas mixture (dry gas concentrations) of 95% O 2 -5% CO 2 by using a Masterflex pump (Cole-Parmer Instruments, Chicago, IL). The peak pressure required to reinflate the lobes was variable and ranged from 13.5 to 32. . After this initial reinflation, the lobes were maintained inflated with a pressure of 4-6 Torr by means of a water-overflow system. To minimize pressure oscillations, a compliance chamber was placed downstream from the pump. The manifold system was placed in a Plexiglas box that was heated to 37°C by perfusing heated water in its walls and humidified. A 10-Fr suction catheter was placed in each of the lobar airways through an airtight port in the manifold system to allow the instillation of plasma and to obtain hourly samples of the airway fluid for protein analysis.
Measurement of ALC. ALC was determined by using the method of Berthiaume et al. (4, 5) . With this approach, increases occurring over time in the protein concentration of plasma instilled in the alveoli represent the loss of fluid from the alveolar compartment. Because the rate of alveolar protein removal is comparatively very slow (,1%/h) (4, 5) , the rate of fluid loss can be calculated by mass balance. For these experiments, autologous plasma was used as the instillate and 1 ml/g lobe weight was instilled in each lobe. During the experiment, samples of the instillate were obtained at hourly intervals for the determination of total plasma protein concentration by refractometry (American Optical refractometer, Buffalo, NY). In preliminary experiments, we found that the American Optical instrument accurately measures the increases in plasma protein concentration that occur as fluid is reabsorbed from the air spaces. In these experiments, plasma was instilled in a variety of canine lung preparations (in situ lungs and isolated perfused lung lobes) under both baseline conditions and after experimental manipulations that increased the rate of ALC [terbutaline administration (3-5, 11, 16, 22, 25) , massive sympathetic nervous system (SNS) activation (17)]. Plasma samples were periodically drawn for protein analysis by refractometry and by the Waddell method (28) . In 45 plasma samples obtained from 7 experiments, we found a high degree of correlation (r 5 0.99, r 2 5 0.98, P , 0.001) between plasma protein determinations from the two techniques. The slope of the regression line (y-axis 5 refractometry, x-axis 5 Waddell method) was 1.021.
The volume of instilled plasma remaining in the lung at each sampling time (V t ) was calculated by mass balance (4, 5)
where V i is the initial instilled volume, C pi is the initial protein concentration, and C pt is the protein concentration of the sample at time t. ALC at each sampling time (ALC t ), expressed as a percentage of the volume instilled, was calculated as (23)
where F wi and F wt are the water fractions of the initial plasma instillate and that at time t, respectively. These were determined gravimetrically.
Experimental protocols. Four groups of experiments (n 5 6 for each group) were conducted. In the first experiment of each group, the LLL [44.3 6 7.4 (SD) g], RLL (41.5 6 7.6 g), and RML (18.3 6 6.3 g) were attached to the manifold at positions 1, 2, and 3, respectively. In each subsequent experiment, each lobe was moved down the manifold one position (e.g., in the second experiment, the LLL, RLL, and RML were attached at positions 2, 3, and 1, respectively). The first group of experiments (group 1) was designed to determine the variability in baseline levels of ALC among the three lung lobes. The lobes in these experiments received the plasma instillate only. The second group of experiments (group 2) was identical to the first with the exception that the b-adrenergic agonist terbutaline (10 25 M, Sigma Chemical, St. Louis, MO) was added to the plasma instillate. This group was performed to determine the extent to which the lobes remained responsive to b-adrenergic-receptor stimulation and the variability in stimulated rates of ALC among the three lobes.
The third and fourth groups of experiments were performed to examine the feasibility of using this approach to evaluate the effects of multiple experimental interventions on ALC in a single experiment. To do so, in group 3 we instilled plasma into the air spaces of one lobe (control lobe), plasma containing terbutaline (10 25 M) into the second lobe, and plasma containing both terbutaline (10 25 M) and propranolol (10 24 M, Sigma Chemical), a b-adrenergic antagonist, into the third lobe. In group 4, ouabain (10 23 M, Sigma Chemical), a Na 1 -K 1 -ATPase inhibitor, was substituted for propranolol.
Statistical analysis. The data from groups 1 and 2 were analyzed by repeated-measures analysis of variance (ANOVA) with the three lobes from each animal (LLL, RLL, RML) as the three repeated measurements, control (group 1) vs. terbutaline treatment (group 2) as a grouping factor, and the three possible positions of the lobes on the manifold as another grouping factor. Data from groups 3 and 4 were analyzed by ANOVA followed by a Student-Newman-Keuls test to determine differences among treatments in the experiments. Paired comparisons were made by paired Student's t-test. A Pearson product moment correlation test was used to determine possible correlations between selected data. terbutaline was administered (18 lobes from group 2 plus the 12 lobes from groups 3 and 4 in which terbutaline was administered; n 5 30). At the end of this period, an average 16.5 6 0.6% (SE) of the instilled fluid had been removed from the air spaces of the lobes in which ALC was determined under baseline conditions (n 5 30), whereas ALC was nearly doubled (30.2 6 1.3%) in the terbutaline-stimulated lobes (n 5 30). These values were similar to those observed by Berthiaume et al. (4) in the lungs of anesthetized dogs under both baseline conditions and after terbutaline administration (Fig. 1) . The relative time courses of the changes in ALC for the control and terbutaline-stimulated lobes are shown in Fig. 2 . In the control lobes, ALC increased at a relatively constant rate during the first 3 h but decreased significantly (P , 0.05) during the last hour. In the terbutaline-stimulated lobes, ALC accelerated during the first 3 h and exhibited a constant increased rate after this time. In the control lobes, there was a significant relationship (r 5 0.55, P 5 0.002) between the initial peak inflation pressure required to reinflate the lobes and ALC (Fig. 3) . There was no significant relationship between ALC and the maintenance inflation pressure (range 4-6 Torr) in the control lobes.
The individual values for ALC for groups 1 (baseline ALC) and 2 (terbutaline administration) are shown in Tables 1 and 2 , respectively. The results of the ANOVA indicated that there was a highly significant difference (P , 0.005) between treatments (control vs. terbutaline). There were no significant treatment-lobe, treatment-manifold position, lobe-manifold position, or treatment-lobe-manifold position interactions. For each experiment, we calculated the SD of the mean ALC for the three lobes as an index of variation. The SD of the mean ALC averaged 2.2% for the control lobes and 3.5% for the terbutaline-stimulated lobes. In group 3, propranolol administration inhibited the terbutalinestimulated increase in ALC (P , 0.05; Fig. 4) . In group 4, ouabain administration decreased ALC in the terbutaline-treated lobes to 3.9 6 1.4% (SE), a value that was ,25% of that of the control lobes (P , 0.05; Fig. 4 ).
Because the release of endogenous catecholamines has been recently shown to increase ALC in pathological conditions in which the SNS has been activated (21), we measured plasma catecholamine concentrations before and after administering the anesthetic overdose to ensure that the overdose did not result in SNS activation. No increases in plasma catecholamine concentrations were observed as a result of the overdose. In fact, plasma norepinephrine (NE) concentration was less (P , 0.05) after the anesthetic overdose (baseline: 214.1 6 27.1 pg/ml, overdose: 66.4 6 11.8 pg/ml). Because plasma NE concentration is determined by the balance of sympathetic overflow into the blood on one hand and by uptake, catabolism, and excretion on the other, the observed reductions in NE concentration could reflect some combination of decreased NE spillover into the blood and continuing uptake and metabolism by erythrocytes (9) before the left ventricular blood sample is obtained. In contrast, no reduction in the mean plasma epinephrine concentration (baseline: 21.8 6 8.9 pg/ml, overdose: 25.9 6 7.9 pg/ml) was observed. This apparent difference in response probably resulted because no epinephrine was detectable in the blood under baseline conditions in 17 of the 24 animals. There was no relationship between plasma catecholamine concentrations at either sampling period and ALC in the lobes administered terbutaline.
DISCUSSION
Several recent studies (11, 22, 23) have indicated that lungs deprived of perfusion retain the ability to reabsorb fluid from their air spaces for extended periods. These observations indicate that the sodium and water transport mechanisms of the alveolar epithelium can remain functional for hours in the absence of perfusion and suggest that the nonperfused lung might be a useful preparation to study alveolar epithelial sodium and water transport. In this study, we initially confirmed these observations by finding that the alveolar epithelium of isolated nonperfused canine lung lobes, inflated to a constant pressure, retained its ability to remove fluid from the air spaces and remained responsive to b-adrenergic-receptor stimulation. At the end of 4 h, the volumes of fluid cleared from the air spaces under both baseline conditions [16.5 6 0.6% (SE)] and after terbutaline administration (30.2 6 1.3%) were similar to those values previously observed by Berthiaume et al. (4) from the lungs of anesthetized dogs (Fig. 1) . The overall volumes of liquid cleared from the air spaces of the nonperfused dog lung lobes over the 4-h observation period under both baseline and terbutaline-stimulated conditions were also similar to the respective values [12 6 1 (SE) and 28 6 3%] observed by Sakuma et al. (22) to occur in nonperfused human lung lobes.
A major objective of this study was to determine the variability in both baseline and b-adrenergic-stimulated rates of alveolar fluid reabsorption between lung lobes from the same animal (groups 1 and 2). Under these conditions, potential differences in ALC resulting from interanimal variability are eliminated, and any variation should thus reflect experimental variability or possible differences in intrinsic sodium and fluid reabsorptive capacity between different lung lobes. Although there has generally been good agreement in results between the many studies that have measured ALC by using the method used in this study, questions have been raised as to how evenly the instilled fluid is distributed with respect to the absorbing surface area, whether there is spatial heterogeneity in epithelial transport in the lung, and what contribution, if any, such factors might have on the degree of experimental variation (24) . The results of this study suggest that these factors do not create a significant degree of variation. In this regard, the SD of the mean ALC for each experiment of three lobes tended to be very small under both baseline and terbutaline-stimulated conditions (Tables 1 and 2 ) and was of a magnitude that allowed clear differentiation between the two experimental groups. The absence of a difference in ALC in the three lobes under both baseline conditions and after terbutaline stimulation also indicated that there was no difference in reabsorptive capability between lung lobes from the same animal. Because the RML was less than one-half the size of the LLL and RLL, these data also indicate that it is possible to obtain equivalent results when measuring ALC in different size lung lobes by scaling the volume of instillate to match the lobe size. Although the variation in ALC in a given series of three lobes tended to be small, a relatively wide range of ALC estimates (e.g., Table 1 , experiment 6) was occasionally obtained. The observation of a significant correlation between ALC and the maximum pressure used to initially reinflate the lung lobes during the setup (Fig. 3) suggests that this factor might contribute to the variation. [Although, the reinflation pressure was slightly greater for the RML (26.2 Torr) compared with the LLL (22.9 Torr) and RLL (22.3 Torr), this small difference in pressure was not of sufficient magnitude to produce higher values for ALC in experiments using the RML (Table 1 ).] The most likely explanation for this correlation is that the higher inflation pressures reopened more atelectatic alveoli, thus increasing the reabsorptive surface area. If so, it might be possible to decrease this variation in ALC by ensuring that all lobes in a given experiment are exposed to the same pressure when reinflated. Another possible explanation is based on recent evidence suggesting that the amiloride-sensitive epithelial sodium channel might be mechanosensitive and respond to increased stretch by increasing its open probability (1) . Thus the higher reinflation pressures might have increased sodium transport and, consequently, fluid reabsorption. This explanation would seem to be less likely, however, because it would require the initial reinflation to have a continuing effect on sodium transport for hours after the pressure was reduced.
In the experiments in which terbutaline was administered to all three lobes (group 2), relatively large differences in the mean ALC of the three lobes were observed between animals ( Table 2) . In this regard, the mean ALC ranged from 25.0 to 41.1%. Because the variation in ALC of the three lobes removed from the same animal tended to be small, the relatively large interanimal variability observed in this group suggests that there may be individual differences in the ability of lungs from different animals to respond to b-adrenergic stimulation. The reason for this variability is not clear. Inasmuch as there was no relationship between plasma catecholamine concentrations and ALC in the terbutaline-stimulated lobes, it is not likely that the interanimal variability can be explained by variable amounts of additional stimulation by endogenous catecholamines. Also supportive of this conclusion is that the basal plasma catecholamine concentrations (10 210 to 10 29 M) are approximately four to five orders of magnitude lower than the airway fluid terbutaline concentration (10 25 M).
Our final objective was to explore the feasibility of using this approach to evaluate multiple experimental interventions using different lung lobes from the same animal. To do so, we compared ALC in a control lobe, a lobe in which ALC had been increased by the administration of terbutaline, and in a third lobe in which both terbutaline and either the b-adrenoceptor antagonist propranolol or the Na 1 -K 1 -ATPase inhibitor ouabain had been added. Previous investigations have found that propranolol effectively inhibits terbutaline-stimulated increases in ALC or sodium transport in the lungs of other species (5, 8, 11, 22) and that ouabain can substantially inhibit baseline rates of sodium transport or fluid reabsorption (2, 14, 16, 22, 27) . The present results indicate that they are effective in the nonperfused dog lung as well. In this regard, propranolol almost completely reduced the elevated ALC produced by terbutaline to baseline levels, and ouabain decreased ALC to values below control levels (Fig. 4) . These data thus demonstrate the practicality of using this approach in studies of this design.
In the isolated lung, it was possible to easily obtain serial airway fluid samples for protein analysis to follow the time course of fluid reabsorption. Fluid clearance was continuous in both groups of lobes, with the rate of clearance being greater in the terbutalinetreated lobes over the time course of the study (Fig. 2) . We did observe, however, that in the lobes studied under baseline conditions, the rate of ALC dropped by ,68% in the last hour after remaining relatively constant for the first 3 h (Fig. 2) . In contrast, Sakuma et al. (22) observed that ALC remained constant during the initial and final 2-h periods of their study of nonperfused human lungs. Although the reason for the decrement in ALC observed in our study is not clear, there are a number of possible explanations. Excess fluid is thought to be removed from the alveoli osmotically by a mechanism involving the active transport of sodium across the alveolar epithelial type II cell (20, 24) . The enzyme Na 1 -K 1 -ATPase, located in the basolateral membrane (26) , is considered to decrease the intracellular sodium concentration, allowing sodium in the alveolar fluid to enter the cell through multiple specialized pathways in the apical membrane (20, 24) . Recent studies have suggested that water follows passively through specialized epithelial water channels (12, 15) . A reduction in ALC could have thus resulted from either a decrease in Na 1 -K 1 -ATPase activity, a decrease in sodium permeability of the apical side of the cell, or a decrease in water permeability. Although any of these possible changes could be regarded as being indicative of a loss of viability, they could very well also represent regulated changes in a viable epithelium. Suggestive of the latter possibility is that the rate of ALC remained accelerated during the entire 4-h experiment in the terbutaline-stimulated lobes (Fig. 2) . This observation also suggests that neither a reduction in energy substrates required for active sodium transport, a reduction in the surface area available for reabsorption, nor an increase in alveolar protein clearance (which would reduce the increase in airway fluid protein concentration) or protein permeability (which could prevent the instillate protein concentration from increasing or attenuate the transepithelial sodium concentration gradient) can explain the reduced ALC. Finally, we considered the possibility that the reduction in ALC could have resulted from sampling error because the first three hourly samples were withdrawn from the http://jap.physiology.org/ airway cannulas, whereas the final sample was a well-mixed sample obtained at the end of the experiment. It is not likely that mixing was a problem, however, because the airway fluid samples were obtained in an identical manner in the terbutaline experiments.
In conclusion, the results of this study indicate that the alveolar epithelium of this preparation retains its ability to transport sodium and water for hours after the cessation of perfusion. Over the course of the 4-h observation period, the nonperfused lobes exhibited baseline and b-adrenoceptor-stimulated rates of alveolar fluid clearance indistinguishable from those observed in intact dogs, and the stimulated increases in ALC could be reversed by b-adrenoceptor blockade and Na 1 -K 1 -ATPase inhibition. Additionally, no intrinsic differences in the ability of individual lung lobes to reabsorb fluid were observed. The maintained viability of the alveolar epithelium in the absence of perfusion eliminates the technical requirements for perfusion and should allow the investigator to easily conduct experiments where each animal could serve as its own control and multiple interventions could be evaluated in a single experiment. Finally, the ability to easily obtain serial airway fluid samples during the experiment will allow for experiments designed to follow the time course of ALC.
